These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32394689)

  • 1. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
    Çiftçiler R; Haznedaroğlu İC
    Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
    [No Abstract]   [Full Text] [Related]  

  • 2. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
    Sever P; Johnston SL
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 challenging cell biology.
    Bullerdiek J
    Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
    [No Abstract]   [Full Text] [Related]  

  • 4. Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?
    Giollo A; Cioffi G; Rossini M; Viapiana O; De Simone G
    Eur J Intern Med; 2020 Oct; 80():106-107. PubMed ID: 32553588
    [No Abstract]   [Full Text] [Related]  

  • 5. Androgen hazards with COVID-19.
    Sharifi N; Ryan CJ
    Endocr Relat Cancer; 2020 Apr; 27(6):E1-E3. PubMed ID: 32302975
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
    Cao Z; Wu Y; Faucon E; Sabatier JM
    Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 8. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine and metabolic link to coronavirus infection.
    Bornstein SR; Dalan R; Hopkins D; Mingrone G; Boehm BO
    Nat Rev Endocrinol; 2020 Jun; 16(6):297-298. PubMed ID: 32242089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
    Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
    Dudoignon E; Moreno N; Deniau B; Coutrot M; Longer R; Amiot Q; Mebazaa A; Pirracchio R; Depret F; Legrand M
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):453-455. PubMed ID: 32565254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection.
    Kessler T; Schunkert H
    Herz; 2020 Jun; 45(4):323-324. PubMed ID: 32274522
    [No Abstract]   [Full Text] [Related]  

  • 14. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
    Tsioufis C; Dimitriadis K; Tousoulis D
    Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?
    Arnold RH
    Heart Lung Circ; 2020 Jul; 29(7):964-972. PubMed ID: 32564908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations.
    Sichitiu J; Fakhouri F; Desseauve D
    Acta Obstet Gynecol Scand; 2020 Jul; 99(7):952. PubMed ID: 32356302
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?
    Loffredo L; Violi F
    Int J Cardiol; 2020 Aug; 312():136. PubMed ID: 32505331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.